Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR ® /ABASAGLAR ® ) approved in the European Union
Byrd, Richard A., Owens, Rebecca A., Blackbourne, Jamie L., Coutant, David E., Farmen, Mark W., Michael, M. Dodson, Moyers, Julie S., Schultze, A. Eric, Sievert, Michael K., Tripathi, Niraj K., Vahle,Langue:
english
Journal:
Regulatory Toxicology and Pharmacology
DOI:
10.1016/j.yrtph.2017.05.013
Date:
May, 2017
Fichier:
PDF, 1.94 MB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
